Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Global Blood Therapeutics, Inc. (GBT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
29.84+0.09 (+0.30%)
At close: 04:00PM EDT
29.84 0.00 (0.00%)
After hours: 05:26PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
210,866
194,749
123,803
2,108
0
Cost of Revenue
3,787
3,316
1,986
48
-
Gross Profit
207,079
191,433
121,817
2,060
-
Operating Expense
496,666
479,123
365,973
291,644
182,742
Operating Income
-289,587
-287,690
-244,156
-289,584
-182,742
Net Non Operating Interest Income Expense
-19,092
-14,747
-3,975
14,697
8,618
Other Income Expense
-380
-177
578
8,121
-69
Pretax Income
-309,059
-302,614
-247,553
-266,766
-174,193
Tax Provision
525
477
-
-
-
Net Income Common Stockholders
-309,584
-303,091
-247,553
-266,766
-174,193
Diluted NI Available to Com Stockholders
-309,584
-303,091
-247,553
-266,766
-174,193
Basic EPS
-
-4.81
-4.04
-4.57
-3.41
Diluted EPS
-
-4.81
-4.04
-4.57
-3.41
Basic Average Shares
-
62,963
61,334
58,322
51,151
Diluted Average Shares
-
62,963
61,334
58,322
51,151
Total Operating Income as Reported
-289,587
-287,690
-243,172
-281,283
-182,742
Total Expenses
500,453
482,439
367,959
291,692
182,742
Net Income from Continuing & Discontinued Operation
-309,584
-303,091
-247,553
-266,766
-174,193
Normalized Income
-309,584
-303,091
-248,537
-275,067
-174,193
Interest Income
891
720
5,834
-
-
Interest Expense
19,983
15,467
9,809
-
-
Net Interest Income
-19,092
-14,747
-3,975
14,697
8,618
EBIT
-289,076
-287,147
-237,744
-289,584
-182,742
EBITDA
-280,236
-
-
-
-
Reconciled Cost of Revenue
3,787
3,316
1,986
48
-
Reconciled Depreciation
8,840
8,616
10,823
9,932
4,607
Net Income from Continuing Operation Net Minority Interest
-309,584
-303,091
-247,553
-266,766
-174,193
Total Unusual Items Excluding Goodwill
0
0
984
8,301
-
Total Unusual Items
0
0
984
8,301
-
Normalized EBITDA
-280,236
-278,531
-227,905
-287,953
-178,135
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement